HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beth Binnington Selected Research

polyleucine

1/2016Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beth Binnington Research Topics

Disease

6HIV Infections (HIV Infection)
03/2013 - 02/2006
5Infections
12/2019 - 01/2009
2Hemolysis
01/2021 - 01/2018
2Neoplasms (Cancer)
11/2013 - 08/2011
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
06/2011 - 05/2006
2Virus Diseases (Viral Diseases)
07/2010 - 02/2006
1Chronic Disease (Chronic Diseases)
03/2020
1Critical Illness (Critically Ill)
03/2020
1Inflammation (Inflammations)
03/2020
1Ebola Hemorrhagic Fever
01/2020
1Fabry Disease (Fabry's Disease)
12/2016
1Cystic Fibrosis (Mucoviscidosis)
01/2016
1Gaucher Disease (Gaucher's Disease)
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
01/2016
1Ganglioneuroma
11/2013
1Neuroblastoma
11/2013
1Pheochromocytoma
11/2013
1Prostatic Neoplasms (Prostate Cancer)
11/2013
1Carcinoma (Carcinomatosis)
11/2013
1Acquired Immunodeficiency Syndrome (AIDS)
07/2010
1Glioblastoma (Glioblastoma Multiforme)
01/2009

Drug/Important Bio-Agent (IBA)

7GlycosphingolipidsIBA
11/2013 - 02/2006
6globotriaosylceramide (globotriosylceramide)IBA
12/2016 - 01/2009
5Shiga Toxins (Vero Toxin)IBA
01/2016 - 01/2010
4CeramidesIBA
11/2013 - 02/2006
3ChemokinesIBA
03/2020 - 02/2006
3Blood Group Antigens (Blood Groups)IBA
12/2012 - 01/2009
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 01/2018
2Histones (Histone)IBA
01/2016 - 12/2012
2Interleukin-2 (IL2)IBA
07/2010 - 02/2006
2GlycolipidsIBA
01/2010 - 02/2006
1Ferritins (Ferritin)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1CytokinesIBA
03/2020
1quinolineIBA
01/2020
1Antiviral Agents (Antivirals)IBA
12/2019
1Tyrosine (L-Tyrosine)FDA Link
12/2019
1Dasatinib (BMS 354825)FDA Link
12/2019
1Phosphotransferases (Kinase)IBA
12/2019
1Fc Receptors (Fc Receptor)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
12/2016
1GalactosidasesIBA
12/2016
1SphingolipidsIBA
12/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Cholera ToxinIBA
01/2016
1Shiga Toxin (Shigella Toxin)IBA
01/2016
1ChloridesIBA
01/2016
1ToxoidsIBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1LuciferasesIBA
01/2016
1Mutant Proteins (Protein, Mutant)IBA
01/2016
1polyleucineIBA
01/2016
1CarbohydratesIBA
11/2013
1CyclodextrinsIBA
11/2013
1CholesterolIBA
11/2013
1Antineoplastic Agents (Antineoplastics)IBA
11/2013
1AntigensIBA
11/2013
1AntibodiesIBA
11/2013
1Lewis X AntigenIBA
11/2013
1stage-specific embryonic antigen-4IBA
11/2013
1stage-specific embryonic antigen-3 (GL-X)IBA
11/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2013
1Cancer VaccinesIBA
11/2013
1Stage-Specific Embryonic AntigensIBA
11/2013
1Histone Deacetylase InhibitorsIBA
12/2012
1Lysergic Acid Diethylamide (LSD)IBA
06/2011
1Pharmaceutical PreparationsIBA
05/2006
1adamantyl-globotriaosyl ceramideIBA
02/2006

Therapy/Procedure

3Therapeutics
01/2021 - 02/2006
1Aftercare (After-Treatment)
07/2010